Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2026 ended April 3, 2026. "Exponent delivered ...
StockStory.org on MSN
Exponent (NASDAQ:EXPO) beats expectations in strong Q1 CY2026
Scientific consulting firm Exponent (NASDAQ:EXPO) announced in Q1 CY2026, with sales up 21% year on year to $166.3 million.
MENLO PARK, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (EXPO) today reported financial results for the fourth quarter and fiscal year 2024 ended January 3, 2025. "Our fourth quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results